These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 34622843

  • 21. Positron emission tomography/computed tomography scan of Vogt-Koyanagi-Harada syndrome with associated autoimmune thyroid disease: A case report and literature review.
    Huang KH, Tai MC, Lee LC, Weng TH, Chen YH, Lin LF, Chen JT, Lu DW, Chen CL.
    Medicine (Baltimore); 2018 Mar; 97(9):e0047. PubMed ID: 29489658
    [Abstract] [Full Text] [Related]

  • 22. Early phase Vogt-Koyanagi-Harada Disease in Nepalese Elderly woman: A case report.
    Bahadur BT, Gurung S, Singh S, Aryal M.
    Nepal J Ophthalmol; 2020 Jan; 12(23):146-152. PubMed ID: 32799253
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
    Caso F, Rigante D, Vitale A, Costa L, Bascherini V, Latronico E, Franceschini R, Cantarini L.
    Clin Rheumatol; 2015 Oct; 34(10):1817-20. PubMed ID: 25224382
    [Abstract] [Full Text] [Related]

  • 30. Clinical Presentation, Management, and Long-Term Outcome of Pars Planitis, Panuveitis, and Vogt-Koyanagi-Harada Disease in Children and Adolescents.
    Reiff A.
    Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1589-1596. PubMed ID: 31444859
    [Abstract] [Full Text] [Related]

  • 31. Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis.
    Park JG, Callaway NF, Ludwig CA, Mahajan VB.
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100859. PubMed ID: 32793845
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
    Herbort CP, Mantovani A, Bouchenaki N.
    Int Ophthalmol; 2007 Sep; 27(2-3):173-82. PubMed ID: 17457515
    [Abstract] [Full Text] [Related]

  • 39. Magnetic resonance imaging of pachymeningeal enhancement in Vogt-Koyanagi-Harada disease.
    Han HJ, Kim HY, Park JH, Lee EJ, Kim DG, Shin DI.
    Neurol Sci; 2010 Dec; 31(6):785-8. PubMed ID: 20198496
    [Abstract] [Full Text] [Related]

  • 40. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
    Karacorlu M, Arf Karacorlu S, Ozdemir H.
    Eur J Ophthalmol; 2006 Dec; 16(3):481-3. PubMed ID: 16761256
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.